ANDREWS PHARMACY LIMITEDActive
Key figures
Like most small UK companies, ANDREWS PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 239,144 | 1,372,276 | 1,311,794 | 1,314,901 | 1,666,561 |
| Total assets | 1,262,466 | 2,015,713 | 2,031,182 | 2,160,792 | 2,489,576 |
| Total liabilities | 632,166 | 729,503 | 665,076 | 689,027 | 758,599 |
| Net assets / total equity | 630,300 | 1,286,210 | 1,366,106 | 1,471,765 | 1,730,977 |
| Average number of employees | 68 | 84 | 62 | 53 | 54 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: ANDREWS PHARMACY LIMITED
Company
ANDREWS PHARMACY LIMITED is a private limited company registered with Companies House under company number 04339538. It was incorporated on 13 Dec 2001. Its status is active. The registered office is in Macclesfield (SK10). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460), dispensing chemist in specialised stores (47730), postal activities under universal service obligation (53100).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files small company accounts (filleted). Net assets were £1,730,977, up 17.6% on the previous year. Cash at bank and in hand was £1,666,561. Total assets were £2,489,576 and total liabilities £758,599. The company had an average of 54 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
2 persons with significant control are registered. 1 of 1 registered charges are outstanding.
Filing deadlines
The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 27 Dec 2026.